RESEARCH FOCUS: Sarcoma tumor biology.
Laurence Baker, Professor Emeritus
J. Chad Brenner, Assistant Professor
RESEARCH FOCUS: Bioinformatics, high-throughput siRNA/drug screening and functional genomics approaches to understand cancer biology and discover novel small molecule therapeutics.
Christine Canman, Associate Professor
RESEARCH FOCUS: Cancer cell biology, signal transduction, responses to DNA replication stress and DNA damaging chemotherapeutic drugs, genome stability and DNA repair.
Adam Courtney, Assistant Professor
RESEARCH FOCUS: Signal transduction in the immune system, T cell signaling pathways, immunotherapy strategies, protein regulation, and cancer therapeutics.
Paul Hollenberg, Professor Emeritus
RESEARCH FOCUS: Chemical carcinogenesis: metabolic activation and detoxication of carcinogens, mechanisms of carcinogen-activating enzymes, cytochrome P-450 and biological oxidations and peroxidations.
Kyoung Eun Lee, Assistant Professor
RESEARCH FOCUS: Pancreatic cancer, hypoxia and immune cells.
Carole Parent, Professor
RESEARCH FOCUS: Signal transduction pathways, inflammation, immune responses, tissue repair, and cancer metastasis.
Manojkumar Puthenveedu, Associate Professor
RESEARCH FOCUS: GPCR trafficking and signaling, opioid, drug addiction.
James Rae, Associate Professor
RESEARCH FOCUS: Predicting response to breast cancer therapies by way of pharmacogenetic, pharmacogenomic, drug metabolism and candidate gene pathway analyses.
Peter J. H. Scott, Associate Professor
RESEARCH FOCUS: Adaptation of state-of-the-art organic chemistry techniques (including SPOS) for radiochemical applications, Microwave mediated radiochemistry, Development of multi-modality biomarkers for PET-MRI.
Judith Sebolt-Leopold, Research Professor
RESEARCH FOCUS: Drug discovery, molecular pharmacology, assay development, and biomarker validation.
Gregory Tall, Associate Professor
RESEARCH FOCUS: Heterotrimeric G protein Signaling, G protein folding chaperones, Mechanisms of Adhesion GPCR action, Somatic G protein disease mutations, GNAQ/11-driven uveal melanoma, High throughput screening and small molecule probe discovery.